Oryzon Genomics S.A. (BME:ORY)

Oryzon Genomics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 18, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	218	245	91	115	133	142
Market Cap Growth	5.79%	170.69%	-21.18%	-13.63%	-6.58%	-32.20%
Enterprise Value	208	232	99	121	129	124
Last Close Price	2.81	3.11	1.40	1.89	2.48	2.70
Forward PE	-	-	106.87	-	-	-
PS Ratio	19.95	22.43	12.31	8.10	8.48	13.42
PB Ratio	-	2.08	1.03	1.41	1.83	2.00
P/TBV Ratio	-	2.08	1.03	1.41	1.85	2.02
EV/Sales Ratio	18.98	21.24	13.40	8.53	8.19	11.66
Debt / Equity Ratio	-	0.15	0.18	0.22	0.31	0.25
Net Debt / Equity Ratio	-	-0.09	0.12	0.07	0.02	-0.16
Net Debt / EBITDA Ratio	-	1.90	-2.42	-1.36	-0.23	1.63
Net Debt / FCF Ratio	-	4.39	-1.83	-10.46	-0.64	2.95
Asset Turnover	-	0.09	0.07	0.14	0.16	0.11
Inventory Turnover	-	84.23	67.11	30.80	8.17	3.55
Quick Ratio	-	1.94	0.74	0.87	1.34	3.75
Current Ratio	-	1.95	0.75	0.87	1.34	3.76
Return on Equity (ROE)	-	-2.53%	-4.21%	-4.35%	-5.88%	-6.37%
Return on Assets (ROA)	-	-2.81%	-2.60%	-2.71%	-3.45%	-4.63%
Return on Capital Employed (ROCE)	-	-4.40%	-4.60%	-5.00%	-6.50%	-8.10%
Earnings Yield	-1.02%	-1.06%	-3.95%	-2.92%	-3.18%	-3.29%
FCF Yield	-	-0.98%	-6.39%	-0.50%	-1.44%	-2.67%
Buyback Yield / Dilution	-19.72%	-19.72%	-6.35%	-10.10%	-4.80%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.